Healthcare tech vendors operate under constraints that most B2B categories simply do not face. Regulatory requirements shape what tools can be used and how. Buying committees involve five to seven stakeholders with fundamentally different priorities. Cycles stretch to 6 to 12 months due to procurement review, compliance evaluation, and board-level approval for larger systems.
Mid-market SaaS companies, roughly $5M to $50M ARR, face a demand gen paradox. They are too large to grow on SEO and content marketing alone, but too small to afford or operationalize an enterprise-grade ABM stack. The platforms built for startups do not generate enough pipeline. The platforms built for enterprise require more operational overhead than a lean team can absorb.
B2B marketers often use “demand generation” and “lead generation” interchangeably, but they are fundamentally different strategies with different goals, timeframes, and success metrics. Understanding the distinction is critical for building a marketing program that actually drives revenue.
Most B2B companies run lead generation and call it demand generation.
Demand generation is not a tactic. It’s a system.
There’s a persistent argument in B2B marketing: demand generation or ABM? Which is better?
B2B demand gen platforms now span paid media, ABM, intent data, and content syndication, and the right tool depends on your primary pipeline motion (paid, ABM, intent, or account-based lead gen hybrid), not on generic feature breadth.
ABM and lead gen are not a binary choice: the right strategy depends on your market size, deal value, and buying cycle length. Enterprise B2B teams that try to pick between them are asking the wrong question.
Canada’s B2B market is one of the fastest-growing in North America. But Canadian B2B teams operate under a regulatory environment most US marketers have never heard of: CASL (Canada’s Anti-Spam Legislation).
Demand capture is reaching prospects who are actively searching for solutions. You’re not creating demand; you’re capturing existing demand when it matters most.
Demand generation has fragmented into at least four distinct problems: identifying who to target, personalizing the experience when they engage, executing the campaigns and outreach, and measuring what actually drove pipeline. No single platform solves all four equally well.
Healthcare tech vendors operate under constraints that most B2B categories simply do not face. Regulatory requirements shape what tools can be used and how. Buying committees involve five to seven stakeholders with fundamentally different priorities. Cycles stretch to 6 to 12 months due to procurement review, compliance evaluation, and board-level approval for larger systems.